Back to Research Hub
Illumina, Inc.
ILMN
$160.03+1.99 (+1.26%)
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture,…
StreetsValue research for Illumina, Inc. (ILMN)
Members get the full report for Illumina, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.